Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

Ewout W. Steyerberg; Karel G.M. Moons; Daniëlle van der Windt; Jill A. Hayden; Pablo Perel; Sara Schroter; Richard D Riley; Harry Hemingway; Douglas G. Altman; for the PROGRESS Group

doi:10.1371/journal.pmed.1001381

Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

Ewout W. Steyerberg(Erasmus MC), Karel G.M. Moons(University Medical Center Utrecht), Daniëlle van der Windt(Keele University), Jill A. Hayden(Dalhousie University), Pablo Perel(University of London), Sara Schroter, Richard D Riley(University of Birmingham), Harry Hemingway(University College London), Douglas G. Altman(University of Oxford), for the PROGRESS Group

PLoS Medicine

February 5, 2013

10.1371/journal.pmed.1001381

Cited by 1,529Open Access

Full Text

Abstract

Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.

Related Papers

No related papers found

Powered by citation graph analysis